Were you seeking one last SB1070 event before the Supreme Court hears argument this Wednesday on Arizona’s controversial immigration law? If so, this evening is for you.
Head over to the ASU Cronkite School at 6:00 tonight for a MALDEF panel on the law and its repercussions. Here is all the detail from the group.
Speakers will Discuss Upcoming Supreme Court Oral Arguments and Other Pending Lawsuits
PHOENIX, AZ – MALDEF President and General Counsel Thomas A. Saenz will speak alongside a distinguished panel of legal scholars and advocates at a major forum discussing upcoming oral arguments before the Supreme Court in State of Arizona v. U.S., the federal government’s case against Arizona’s anti-immigrant law SB 1070. Oral arguments before the Supreme Court are scheduled for Wednesday, April 25, 2012.
MALDEF and a coalition of civil rights organizations have been at the forefront of the battle to challenge all of the discriminatory and unconstitutional provisions in SB 1070.
WHAT: Major Forum on upcoming Supreme Court oral arguments in State of Arizona v. U.S., the federal government’s case against anti-immigrant law SB 1070. Presentation and discussion will include: the major arguments from either side; impact on other pending lawsuits against SB 1070; amicus briefs; the make-up of the court; and other FAQs.
WHO: Thomas A. Saenz, MALDEF President and Counsel, will be in attendance.
Also speaking will be: Dan Pochoda, ACLU of Arizona; Evelyn Cruz, Arizona State University Law Professor; Crystal Lopez, DLA Piper; and Daniel Ortega, Ortega Law Firm.
WHEN: Monday, April 23, 2012, 6–8 p.m.
WHERE: Cronkite School of Journalism, ASU Downtown Campus, Cronkite Theater, 555 N. Central Ave., Phoenix, AZ 85004
MALDEF: Founded in 1968, MALDEF is the nation’s leading Latino legal civil rights organization. Often described as the “law firm of the Latino community,” MALDEF promotes social change through advocacy, communications, community education, and litigation in the areas of education, employment, immigrant rights, and political access.
For more information on MALDEF, please visit here.